FDA Approved: MOMETASONE FUROATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for mometasone furoate from Glenmark Pharmaceuticals Inc., USA under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Atopic Dermatitis

Drugs mentioned

• Mometasone furoate (Mometasone furoate)

Snippet

SUPPL AP for MOMETASONE FUROATE (MOMETASONE FUROATE)